Huntington's Disease Therapeutics Market Report

Global and China Huntington's Disease Therapeutics Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 22, 2022
  • PAGES：209
  • REPORT CODE：GMM1396608
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Huntington's disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington's disease develop signs and symptoms in their age of 30 to 40.

    This report elaborates on the current development of the Huntington's Disease Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • F Hoffmann-La Roche

    • H Lundbeck

    • Prana Biotechnology

    • Teva Pharmaceutical Industries

    • Horizon Pharma

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Antidopaminergics

    • Anticonvulsants

    • Antipsychotics

    • Antidepressants

    Application:

    • Hospitals

    • Clinics

    • Diagnostic Centers

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Huntington's Disease Therapeutics Industry Overview

      • 1.1.1 Huntington's Disease Therapeutics Market Scope and Market Segments

      • 1.1.2 Huntington's Disease Therapeutics Industry Characteristics

      • 1.1.3 Global and China Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Huntington's Disease Therapeutics Production Value and Growth Rate (2017-2028)

    • 1.2 Global Huntington's Disease Therapeutics Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Antidopaminergics

      • 1.2.2 Anticonvulsants

      • 1.2.3 Antipsychotics

      • 1.2.4 Antidepressants

    • 1.3 Global Huntington's Disease Therapeutics Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals

      • 1.3.2 Clinics

      • 1.3.3 Diagnostic Centers

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Huntington's Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Huntington's Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Huntington's Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Huntington's Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Huntington's Disease Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Huntington's Disease Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Huntington's Disease Therapeutics Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Huntington's Disease Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Huntington's Disease Therapeutics Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Huntington's Disease Therapeutics Industry Porter's Five Forces Model Analysis

      • 2.2.3 Huntington's Disease Therapeutics Industry PEST Analysis

    • 2.3 Huntington's Disease Therapeutics Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Huntington's Disease Therapeutics Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Huntington's Disease Therapeutics Industry

    Chapter 3 Global and China Huntington's Disease Therapeutics Market, by Manufacturer

    • 3.1 Global and China Huntington's Disease Therapeutics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Huntington's Disease Therapeutics Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Huntington's Disease Therapeutics Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Huntington's Disease Therapeutics Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Huntington's Disease Therapeutics Market Top 3 Players

    Chapter 4 Global and China Huntington's Disease Therapeutics Market, by Type (2017-2028)

    • 4.1 Huntington's Disease Therapeutics Market Trend, by Type

    • 4.2 Global Huntington's Disease Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Huntington's Disease Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Huntington's Disease Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Huntington's Disease Therapeutics Price Trend, by Type (2017-2028)

    • 4.3 China Huntington's Disease Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Huntington's Disease Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Huntington's Disease Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Huntington's Disease Therapeutics Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Huntington's Disease Therapeutics Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Huntington's Disease Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Huntington's Disease Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Huntington's Disease Therapeutics Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Huntington's Disease Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Huntington's Disease Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Huntington's Disease Therapeutics Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Huntington's Disease Therapeutics Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Huntington's Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Huntington's Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Huntington's Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Huntington's Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Huntington's Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Huntington's Disease Therapeutics Market Analysis

    • 7.1 North America Huntington's Disease Therapeutics Market, by Type

    • 7.2 North America Huntington's Disease Therapeutics Market, by Application

    • 7.3 North America Huntington's Disease Therapeutics Market Analysis and Forecast, by Country

      • 7.3.1 United States Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Huntington's Disease Therapeutics Market Analysis

    • 8.1 Europe Huntington's Disease Therapeutics Market, by Type

    • 8.2 Europe Huntington's Disease Therapeutics Market, by Application

    • 8.3 Europe Huntington's Disease Therapeutics Market Analysis and Forecast, by Country

      • 8.3.1 Germany Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Huntington's Disease Therapeutics Market Analysis

    • 9.1 APAC Huntington's Disease Therapeutics Market, by Type

    • 9.2 APAC Huntington's Disease Therapeutics Market, by Application

    • 9.3 APAC Huntington's Disease Therapeutics Market Analysis and Forecast, by Country

      • 9.3.1 China Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Huntington's Disease Therapeutics Market Analysis

    • 10.1 Latin America, Middle East and Africa Huntington's Disease Therapeutics Market, by Type

    • 10.2 Latin America, Middle East and Africa Huntington's Disease Therapeutics Market, by Application

    • 10.3 Latin America, Middle East and Africa Huntington's Disease Therapeutics Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Huntington's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Huntington's Disease Therapeutics Company Profiles

      • 11.1 F Hoffmann-La Roche

        • 11.1.1 F Hoffmann-La Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 F Hoffmann-La Roche Huntington's Disease Therapeutics Product Profiles, Application and Specification

        • 11.1.3 F Hoffmann-La Roche Huntington's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 H Lundbeck

        • 11.2.1 H Lundbeck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 H Lundbeck Huntington's Disease Therapeutics Product Profiles, Application and Specification

        • 11.2.3 H Lundbeck Huntington's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Prana Biotechnology

        • 11.3.1 Prana Biotechnology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Prana Biotechnology Huntington's Disease Therapeutics Product Profiles, Application and Specification

        • 11.3.3 Prana Biotechnology Huntington's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Teva Pharmaceutical Industries

        • 11.4.1 Teva Pharmaceutical Industries Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Product Profiles, Application and Specification

        • 11.4.3 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Horizon Pharma

        • 11.5.1 Horizon Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Horizon Pharma Huntington's Disease Therapeutics Product Profiles, Application and Specification

        • 11.5.3 Horizon Pharma Huntington's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Huntington's Disease Therapeutics Industry Investment Prospect and Risk Assessment

    • 12.1 Huntington's Disease Therapeutics Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Huntington's Disease Therapeutics Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Global Huntington's Disease Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure China Huntington's Disease Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure Global Huntington's Disease Therapeutics Market Size and Growth Rate of Antidopaminergics (2017-2028)

    • Figure Global Huntington's Disease Therapeutics Market Size and Growth Rate of Anticonvulsants (2017-2028)

    • Figure Global Huntington's Disease Therapeutics Market Size and Growth Rate of Antipsychotics (2017-2028)

    • Figure Global Huntington's Disease Therapeutics Market Size and Growth Rate of Antidepressants (2017-2028)

    • Figure Global Huntington's Disease Therapeutics Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Huntington's Disease Therapeutics Market Size and Growth Rate of Clinics (2017-2028)

    • Figure Global Huntington's Disease Therapeutics Market Size and Growth Rate of Diagnostic Centers (2017-2028)

    • Figure North America Huntington's Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Huntington's Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Huntington's Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Huntington's Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Huntington's Disease Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Huntington's Disease Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Huntington's Disease Therapeutics Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Huntington's Disease Therapeutics Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Huntington's Disease Therapeutics Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Huntington's Disease Therapeutics Market Share, by Manufacturer in 2021

    • Figure Global and China Huntington's Disease Therapeutics Market Share, by Manufacturer in 2022

    • Table Global Huntington's Disease Therapeutics Sales Volume, by Type (2017-2028)

    • Table Global Huntington's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Global Huntington's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Global Huntington's Disease Therapeutics Sales Value, by Type (2017-2028)

    • Table Global Huntington's Disease Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure Global Huntington's Disease Therapeutics Price Trend, by Type (2017-2028)

    • Table China Huntington's Disease Therapeutics Sales Volume, by Type (2017-2028)

    • Table China Huntington's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure China Huntington's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table China Huntington's Disease Therapeutics Sales Value, by Type (2017-2028)

    • Table China Huntington's Disease Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure China Huntington's Disease Therapeutics Price Trend, by Type (2017-2028)

    • Table Global Huntington's Disease Therapeutics Sales Volume, by Application (2017-2028)

    • Table Global Huntington's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Global Huntington's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table Global Huntington's Disease Therapeutics Sales Value, by Application (2017-2028)

    • Table Global Huntington's Disease Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure Global Huntington's Disease Therapeutics Sales Value Share, by Application (2017-2028)

    • Table China Huntington's Disease Therapeutics Sales Volume, by Application (2017-2028)

    • Table China Huntington's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Huntington's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table China Huntington's Disease Therapeutics Sales Value, by Application (2017-2028)

    • Table China Huntington's Disease Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Huntington's Disease Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Huntington's Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure North America Huntington's Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Huntington's Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Huntington's Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Huntington's Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Table North America Huntington's Disease Therapeutics Sales Volume, by Type (2017-2028)

    • Table North America Huntington's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure North America Huntington's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table North America Huntington's Disease Therapeutics Sales Volume, by Application (2017-2028)

    • Table North America Huntington's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure North America Huntington's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure United States Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure United States Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Canada Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Europe Huntington's Disease Therapeutics Sales Volume, by Type (2017-2028)

    • Table Europe Huntington's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Europe Huntington's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Europe Huntington's Disease Therapeutics Sales Volume, by Application (2017-2028)

    • Table Europe Huntington's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Europe Huntington's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Germany Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure UK Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure UK Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure France Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure France Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Italy Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Spain Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Poland Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Russia Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table APAC Huntington's Disease Therapeutics Sales Volume, by Type (2017-2028)

    • Table APAC Huntington's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure APAC Huntington's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table APAC Huntington's Disease Therapeutics Sales Volume, by Application (2017-2028)

    • Table APAC Huntington's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure APAC Huntington's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Japan Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure India Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure India Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Huntington's Disease Therapeutics Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Huntington's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Huntington's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Huntington's Disease Therapeutics Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Huntington's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Huntington's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Huntington's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Huntington's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table F Hoffmann-La Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table F Hoffmann-La Roche Product Profiles, Application and Specification

    • Table F Hoffmann-La Roche Huntington's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table H Lundbeck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table H Lundbeck Product Profiles, Application and Specification

    • Table H Lundbeck Huntington's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Prana Biotechnology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Prana Biotechnology Product Profiles, Application and Specification

    • Table Prana Biotechnology Huntington's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Teva Pharmaceutical Industries Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Teva Pharmaceutical Industries Product Profiles, Application and Specification

    • Table Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Horizon Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Horizon Pharma Product Profiles, Application and Specification

    • Table Horizon Pharma Huntington's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US